A new study found that taking aspirin every two days reduces the risk of dying from breast or bladder cancer by up to a third.
The researchers revealed that aspirin can also improve survival rates from some types of cancer, including bladder and breast cancer.
Building on the findings, the researchers are calling for more population-based evidence to shed light on aspirin’s potential protective effects.
“The results add to the accumulated evidence that aspirin may improve survival for some types of cancer. Although previous research has focused largely on cancers of the digestive system, our analysis has been largely focused on cancers of the digestive system,” said reporter Dr. Holly Lomanes Krupp, of the National Cancer Institute in the United States. It extends to other benefits, such as the bladder and the breast. ”
Its anti-inflammatory properties are also believed to reduce the risk of developing bowel cancer and some other forms of disease.
The results are based on a study of nearly 140,000 men and women in a cancer screening trial in the United States, most of them over 65, who were tracked for up to 13 years.
It turns out that those with breast or bladder cancer who reported taking aspirin at least three times a week were a quarter and a third less likely to die, respectively.
Moreover, any use reduced the risk of dying from disease by 21 and 25%, respectively, compared to those who had not had it before.
These results may indicate that aspirin may be beneficial for some types of cancer. However, a greater benefit may be seen with increased frequency of use.
The trials suggested that the drug fights inflammatory processes in breast and bladder cancer. But it did not reduce the risk of developing, treating, or stopping the four other forms of the disease analyzed – including cancers of the esophagus, stomach, pancreas, or uterus.
Long-term use of aspirin has been associated with a reduced risk of heart disease, stroke, gastrointestinal cancers, and death from any disease.
“Recent research indicates that the use of aspirin may provide protection against the development and death of other types of cancer as well,” said Lomanz-Krupp.
But the benefits and harms in older adults are still a matter of debate.
During the study period, more than 32,500 cancers were diagnosed – including 4,552 breast and 1,751 bladder cancers.
“Numerous studies have evaluated the long-term benefits of aspirin use. However, the association of aspirin use with cancer incidence and survival in older individuals remains uncertain. Although the use of aspirin may confer a cancer protective effect,” said Loomans-Krupp. However, it is still necessary to take into account the damage, as well as the benefits, of long-term aspirin use. ” The medicine can cause dangerous stomach bleeding.
The results are published in the JAMA Network Open.
Source: Daily Mail